Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Morbidity Trend and Care Cost Inflation in Long-Term Care Insurance

Abstract. Long-term care insurance liabilities are determined by the interaction of functional dependency, survival, claim incidence and duration, the organization and price of care, and the exact promises made by insurance contracts. This monograph examines how morbidity trends and care cost inflation jointly alter the expected cost and distribution of insured long-term care obligations. Its central proposition is a measurement and valuation conclusion: changes in the prevalence of dependency, the incidence of payable claims, the duration of insured episodes, the intensity of purchased services, and the price of a comparable unit of care must be separately identified before changes in reserves or premiums can be attributed to morbidity or inflation. The analysis reconstructs the evidentiary development of long-term care experience studies, evaluates observation-based and actual-to-expected trend methods, and distinguishes cohort, period, age, selection, eligibility, benefit design, and provider-market effects. It integrates primary actuarial experience programs, longitudinal disability research, labor-market and care-price measures, insurance regulation, international care-system comparisons, and relevant scholarly work on private information and demand. Formal multi-state, cash-flow, and sensitivity illustrations demonstrate why the effects of higher morbidity and care prices can compound, while contractual benefit ceilings can transfer a substantial portion of the increase to households rather than insurers. The findings support more granular experience analysis, explicit consideration of dependent uncertainty, transparent inflation assumptions, and governance that links policyholder protection with reserve adequacy. All numerical projection exercises are labeled illustrative; no proprietary insurer portfolio, causal experiment, or new authorial theory is claimed.

Keywords: Long-term care insurance; morbidity trend; functional dependency; activities of daily living; cognitive impairment; incidence; claim continuance; competing risks; recovery; disabled mortality; care cost inflation; labor cost; care intensity; home care; nursing home; benefit inflation protection; reimbursement insurance; indemnity insurance; reserves; premium adequacy; multi-state actuarial model; experience study; IFRS 17; actuarial standards; solvency; consumer protection.

Introduction

An insurance promise extending several decades into the future is exposed simultaneously to changes in human dependency and to changes in the resources required to meet that dependency. A policyholder may reach a given age with less functional disability than earlier cohorts, yet encounter higher hourly care prices, fewer available family caregivers, a different distribution of care settings, or a contract whose nominal benefit fails to purchase the same service. Conversely, a deterioration in disability incidence may not translate proportionately into insured expenditures when daily limits, elimination periods, or aggregate benefit pools bind. These possibilities are essential to the actuarial interpretation of long-term care (LTC) experience.

The OECD affordability investigation (OECD 2024) places long-term care at the intersection of functional need, households' financial resources, formal and informal care supply, and public benefits. Its projection of substantially greater demand through 2050 is a demographic and policy scenario rather than an estimated rate of insured morbidity deterioration. That distinction determines the research problem here. A growing number of people requiring care can result from population aging even if age-specific dependency probabilities improve. A higher dollar amount paid for covered claims can reflect more intensive utilization, higher service prices, changed claims practice, or contractual inflation protection without a deterioration in underlying health.

Long-term care is not one uniform insured event. A patient requiring short-term skilled nursing following hospitalization, an older person receiving daily assistance with bathing and dressing, an individual needing continuous supervision because of severe cognitive impairment, and a person receiving public residential support can occupy different clinical, legal, and insurance states. The World Health Organization's ICF classification framework (WHO 2001, maintained online) supplies a useful language of bodily functioning, activity, participation, and environment. The insured definition of dependency remains the contract's own eligibility test, situated within applicable national law. Insurance models must preserve this distinction when projecting morbidity.

The analysis is organized around three questions. First, how can age- and risk-adjusted morbidity trend be measured without conflating exposure composition, disability prevalence, claim incidence, and claim termination? Second, how can the price of care be separated from changes in labor inputs, service intensity, setting, quality, and insurer benefit utilization? Third, how do their joint effects pass through contract terms into premiums, cash flows, accounting liabilities, solvency, and policyholder financial protection?

The method is documentary and analytical. It combines original or officially published actuarial experience reports and research protocols, official statistics and care-price survey methodology, professional standards, and peer-reviewed scholarship. A qualitative and mathematical synthesis applies established frequency-severity decomposition, multi-state actuarial methods, competing risks, and discounted expected cash flow techniques. Illustrative calculations use explicitly invented assumptions to test mechanisms rather than to assert market-wide estimates. The research cutoff is November 15, 2026. Where the available evidence concerns a specific reporting period, country, or insured product class, the claim retains that boundary.

Conceptual Foundations and Historical Development

The risk-bearing unit and the care episode

A transparent analysis begins by identifying the unit exposed to risk. In a stand-alone individual LTC insurance portfolio, the denominator for incidence ordinarily begins with insured lives or policy-years that are eligible to become new claimants during a specified interval. A claim can arise only after medical or functional criteria and applicable waiting rules have been satisfied; the insurer's record of claim payment may begin later than the onset of care need. In a population survey, disability prevalence is instead a cross-sectional or longitudinal property of a defined household or institutional sample. These measures answer distinct questions.

For an insured person, a care episode may involve a sequence of states: active without a payable claim; functionally limited but below the contractual trigger; eligible for benefits but in an elimination period; receiving paid home or community care; assisted living; nursing home care; recovery to nonclaim status; exhaustion of a benefit pool; and death. Transitions can recur. A discharge from a nursing home may mean recovery, transfer to home care, movement to a different paid setting, or death. Treating all such changes as equivalent claim terminations loses information about benefit obligations.

The National Association of Insurance Commissioners' long-term care insurance overview (NAIC, current online guidance) explains the U.S. combination of home and institutional care benefits, historic repricing, and regulatory attempts to coordinate rates. The association specifically identifies past understatement of incidence and claim duration and unexpectedly low lapse rates among issues affecting older policy generations. These are explanations of particular historic pricing experience, not evidence that every modern policy shares the same assumption error.

Experience measurement and the changing knowledge base

Long-duration insurers begin with incomplete lifetime experience because many insured people have not reached high claim ages and some claims remain open. Results mature as policy cohorts age; changes in underwriting, distribution, lapse, contracts, and care environments alter subsequent experience. The SOA long-term care study library (SOA Research Institute, online collection) documents the evolution of separate mortality, lapse, incidence, and other insurance-experience investigations. An industry study cannot retroactively make early pricing certain; it can expose the assumptions that were historically most sensitive.

The SOA's 2000–2016 aggregate database program (SOA 2020) provides separately organized claim incidence and termination datasets and a data-definition report. The distinction matters because a claim start process is fundamentally different from the process that determines how long a claim remains open. The program used multiple contributing insurers; its aggregates and the record definitions must be assessed before transferring rates to a particular portfolio. Its accompanying report documents limitations of insurer contributions and eligibility of records. The data are especially valuable for defining an auditable starting point for experience analysis, while underwriting, benefit design, and historical observation periods remain potential sources of noncomparability.

A further methodological step appears in Researching Long-Term Care Insurance Incidence Rates Over Time (SOA 2018), which describes observation-based and actual-to-model approaches for detecting calendar-year effects. These methods have different vulnerabilities. A raw calendar-year comparison is exposed to changes in portfolio age and other characteristics. An actual-to-expected comparison is exposed to the suitability and vintage of the expected basis. Neither method becomes a causal estimate merely by including the calendar year as a variable.

The SOA and LIMRA's 2000–2023 data request (SOA Research Institute 2025) specifies claim incidence, termination, and utilization for stand-alone individual and group LTC insurance, excluding combination and accelerated-benefit products from that particular program. The August 2025 joint experience-study announcement reports participation plans and a broader initiative by SOA, LIMRA, and NAIC. These documents evidence research design and planned collection, not completed findings for the 2000–2023 period. Until released study results are independently inspected, the project cannot be cited as having established a new morbidity trend.

An additional practitioner perspective is supplied by Milliman's 2025 LTCI claims projection (Milliman 2025). It describes incidence, utilization, continuance, recovery, disabled-life mortality, underwriting selection, and distinct annual cost assumptions for care settings. Its illustrative portfolio projection applies proprietary model assumptions and is analytically informative, while the projection is not a substitute for independently verified insurer-level data. Its published methodological description is useful precisely because it exposes the assumptions whose divergence can compound in a long-duration block.

Population disability, insured selection, and demand

The population experiencing severe limitations is the source of potential care demand, yet the insured subset differs by resources, health at purchase, underwriting rules, geography, and attitudes toward risk. Stallard and Yashin's population morbidity improvement study (2016) examines HIPAA-related activities-of-daily-living disability and cognitive impairment using 1984–2004 National Long Term Care Survey observations. It provides a historically important population-trend analysis. Its observation years, disability definitions, and population sampling do not by themselves establish contemporary morbidity improvement within a private LTCI block.

The importance of selection is strengthened by Finkelstein and McGarry's (2006) study of private information, which found offsetting dimensions of private information associated with health risk and insurance preference in the U.S. market. It is therefore unsafe to assume that insured experience is simply the population experience multiplied by a constant underwriting factor. The risk and preference composition of buyers can change at different rates, and the observed association between purchase and realized claims need not have a uniform sign.

Brown and Finkelstein's (2007) analysis of LTC insurance demand documents the importance of benefit design, loads, and demand-side behavior in the historical U.S. market. The study helps explain why the insured population and the general older population differ; its published historical market outcomes should not be treated as contemporary national market-share statistics. In research on morbidity, these market-selection mechanisms are part of the observation process. In research on care costs, the same mechanisms affect which benefits and services become reimbursed rather than paid privately.

International institutional context

LTC financing spans private indemnity and reimbursement contracts, public entitlement systems, social insurance, and means-tested support. The OECD care affordability report (OECD 2024) compares countries with widely different financing and service configurations. Its observation that older people may face substantial out-of-pocket burdens despite public support has direct relevance for insured benefit adequacy. Still, public spending per older person, household spending on home care, insurer-paid claims, and cost per professional care hour are not interchangeable price series.

This institutional setting also explains why the same aging trajectory can lead to different insurer cash flows. A country that expands subsidized home care may reduce privately reimbursed facility utilization; another that tightens public eligibility may shift expenses toward private insurance and households. Regulatory changes to claim assessments can alter recorded incidence without changing underlying functional need. An international model must therefore hold both clinical and contractual definitions visible rather than reporting a single global LTC morbidity coefficient.

Morbidity Trend Decomposition

What a morbidity trend measures

Morbidity trend is an observed or projected change in the probability, timing, severity, or persistence of a defined functional or cognitive state after accounting for the relevant risk population. A claim incidence trend is narrower: it concerns new qualifying events under the specified coverage, risk set, calendar period, and claim convention. A dependency prevalence trend also depends on survival and duration. A severity trend may change hours of care per dependent person while incidence is unchanged. The terms must be attached to observable variables before a trend assumption can be identified.

Let E[a,c,t] be eligible active insured person-years at attained age a, issue cohort c, and calendar year t. Let N[a,c,t] be the count of new payable episodes recognized under a documented incidence rule. An empirical central incidence rate is

i[a,c,t] = N[a,c,t] / E[a,c,t].

An insurer may require prospective entry counts and exposure measured to claim initiation, with adjustments for delayed reporting or incomplete observation. The formula presupposes compatible numerator and denominator definitions. Counting reopened claims as new incidence, including time already on claim in active exposure, or mixing paid claims with unmet need creates a different estimator. Policy-year, attained-age, issue-age, sex, duration since underwriting, benefit trigger, geography, and contract generation can all require stratification.

To isolate a calendar effect, compare standardized rates over a fixed age-and-cohort distribution, or estimate an experience model with those characteristics. A simple directly standardized rate is I[t] = Σ_g w[g] × i[g,t], with fixed, documented weights w[g] summing to one across comparable cells g. The raw rate Σ_g E[g,t] i[g,t] / Σ_g E[g,t] instead changes whenever the portfolio's exposure distribution changes. Both are valid descriptive statistics, but they quantify different objects.

Age, period, and cohort identification

Attained age, calendar period, and birth cohort obey an exact linear relation. A fully unrestricted model containing all three effects is therefore unidentified without constraints or additional structure. Product issue cohort adds further dependencies because calendar duration equals calendar year minus issue year. Estimating a coefficient labeled 'morbidity improvement' does not resolve this identification problem. A responsible trend analysis documents which dimensions are fixed or constrained, the reason for the constraint, and the sensitivity of conclusions to plausible alternatives.

A plausible age-standardized decline can represent health improvement, a change in which insured lives remain in force, favorable underwriting cohorts, a shift to policies with stricter triggers, or a change in claim notification behavior. Particularly at advanced ages, small exposure and selective mortality can produce unstable apparent trends. Analysts should present cell counts, confidence or uncertainty intervals, and diagnostics for low-exposure groups. The SOA's two incidence-trend approaches are useful precisely because their disagreement can reveal sensitivity to how expectations and composition are specified.

Multi-state dependency and competing exits

A single 'disabled' state may hide the main drivers of care expenditures. Consider states A (active and independent), D (dependent but not contractually payable), H (payable home care), L (assisted living), N (nursing care), R (recovered or below trigger), and X (dead). In continuous time, transition intensities q[j,k](a,t,d) may depend on age, calendar time, and time d already spent in a state. The generator matrix has off-diagonal entries q[j,k] ≥ 0 and each diagonal equal to the negative sum of departures. The row-vector state distribution satisfies dπ(u)/du = π(u) Q(u) in a time-inhomogeneous Markov formulation.

A semi-Markov specification is often more credible for active claims because recovery and mortality intensities can vary materially with elapsed claim duration, even at the same attained age. An equivalent duration-explicit transition model may be used. A claim may also transfer from H to N without ending; a cap or benefit exhaustion may stop payment even if dependency continues. The relationship between clinical transitions and insurer-paid transitions is therefore mediated by the contract.

For a simplified open-claim state with competing recovery and death exit intensities μ_R(u) and μ_X(u), the probability of remaining in that state through duration d is S(d) = exp(-∫_0^d [μ_R(u) + μ_X(u)]du), when those are the only exits. The expected open-claim time is ∫_0^∞ S(d)dd, provided the integral exists. If transfers, exhaustion, administrative closure, or requalification are relevant, they must enter the event system, and recorded termination cannot be interpreted solely as clinical recovery. The SOA aggregate experience database illustrates why distinct incidence and termination records are essential to that analysis.

Observed incidence and actual-to-expected ratios

For each comparable cell g,t, define A[g,t] as new observed events and M[g,t] = E[g,t] i_0[g,t] as expected events under a predeclared reference basis i_0. A portfolio-level actual-to-expected ratio is R[t] = Σ_g A[g,t] / Σ_g M[g,t]. Its interpretation depends on the basis. A rising ratio may indicate deteriorating experience relative to that basis, but it can also arise because the expected model is stale, benefit triggers changed, or reporting developed unevenly. If expected events are very low, ratios become unstable.

A reference basis can be re-estimated on training years, with subsequent data reserved for validation. It should not be silently updated in every comparison year if the objective is to measure change relative to a fixed benchmark. Analysts should report both raw outcomes and standardized A/E ratios; suppressing one hides an important check against compositional artifacts. Onset-year and reporting-year triangles help reveal development delays and shocks to claim processing.

Morbidity improvement and its limits

An improvement assumption is typically encoded through a reduction in age-specific incidence or a favorable shift in recovery and severity. Such a factor requires clinical and statistical definition. For example, a one-percent annual decrease in incidence applied to an unchanged age-specific baseline over 20 years gives 0.99^20 ≈ 0.818 of the baseline rate, all else equal. It does not imply an 18.2 percent reduction in the total number of claims, because future insured exposure, mortality, lapses, and benefit mix also change. Nor does it imply a similar decrease in insured cost if claimant survival or care intensity rises.

The 1984–2004 evidence investigated in Stallard and Yashin's morbidity improvement study deserves scientific attention as a defined longitudinal historical observation. It cannot identify future effects of dementia prevalence, obesity, disability treatment, pandemic aftereffects, or home-care policy without additional evidence and a new observation window. A forward-looking estimate should be a scenario whose assumptions can be falsified against later cohorts.

Causal and descriptive conclusions

Aggregate insured experience frequently supports risk-adjusted description more readily than causal attribution. Better clinical prevention could reduce functional dependency; stricter claim assessments could reduce payable incidence while leaving needs unchanged. Greater survival with impairment could raise disabled-life duration. Increased family assistance could reduce formal insured utilization without changing dependency. A defensible interpretation enumerates such mechanisms, identifies the data that would distinguish them, and avoids converting an estimated calendar coefficient into a causal conclusion about national health improvement.

Labor and Care Cost Inflation

The service purchased versus the price paid

Care cost inflation is the change in the price of a specified care service at comparable quality, location, time unit, and payment arrangement. Total care expenditure also changes with the quantity and composition of purchased services. Write a simplified service budget for care setting s as C[s,t] = U[s,t] × P[s,t], where U is intensity or units (hours, days, visits) and P is price per comparable unit. For several service types, C[t] = Σ_s U[s,t]P[s,t]. Changes in total spending may therefore reflect different quantities, relative prices, or a shift among settings even if the underlying service-specific inflation rates are unchanged.

The payer's price may differ from a publicly advertised private-pay median because of negotiated reimbursement, provider networks, taxes, room-and-board treatment, care intensity, location, and insurance policy restrictions. A nursing-home daily price is not commensurable with an hourly personal-care rate without an assumed schedule and scope. A single annual 'LTC inflation' figure should consequently disclose its basket and weights. If weights shift in response to price or disability, a fixed-weight index and a current-weight index measure different effects, and a decomposition should show the interaction or allocate it by a disclosed conventional method.

CareScout service prices and what they establish

The CareScout 2025 Cost of Care Survey reports national private-pay median prices for several U.S. service categories, based on provider surveys conducted between July and November 2025. It reports a $35 hourly median for nonmedical in-home caregiving, a $6,200 monthly assisted-living median, $315 per day for a semiprivate nursing-home room, and $355 per day for a private nursing-home room. On the survey's illustrative service schedules, these translate to $80,080 a year for 44 hours of home care each week, $74,400 for 12 months of assisted living, $114,975 for a 365-day semiprivate room, and $129,575 for a private room. These are market survey medians under stated use assumptions, not average insurer-paid amounts.

CareScout's survey release and methodology (CareScout 2026) reports more than 25,000 collected rates and year-over-year increases around 1–5 percent in most reported settings, with adult day health care declining. The survey site displays some measures in monthly rather than daily units. Minor differences between rounded daily growth and monthly comparisons can reflect rounding and construction, so annual rates should be quoted in the unit actually used. Geographic cost dispersion and provider sampling limit a national median's predictive power for an individual portfolio. Most critically, a change in the sample mix of providers can influence a repeated survey median even if a constant-service transaction price is unchanged.

The correct actuarial use of such statistics is as a source for external care-price triangulation, calibration checks, and scenarios after adjusting for geography, care setting, provider contract, and product wording. A $35 hourly median times a 24-hour assumption would radically overstate the specific annual figure based on 44 hours per week; conversely, an insurance benefit of $200 per covered day need not pay the actual number of billed hours. Units and utilization assumptions must accompany every monetary figure.

Labor supply, wages, productivity, and quality

LTC services are labor intensive. Personnel costs arise from direct care hours, supervision, scheduling, training, benefits, staffing regulations, agency overhead, and recruiting costs. The same nominal wage change can translate into a different provider cost change because staffing intensity, productivity, overtime, and nonwage expenses change. An approximate cost index for a provider with labor share α is g_C ≈ α g_W + (1−α) g_O + g_Q, where g_W is labor compensation change, g_O nonlabor cost change, and g_Q an explicitly defined quality, productivity, or composition term. The approximation is bookkeeping, not an empirically fitted law.

The U.S. Bureau of Labor Statistics' second-quarter 2026 ECI wage table documents wage and salary changes by industry, including nursing and residential care. It reports a 3.0 percent 12-month change for nursing and residential care facilities in the published June 2026 table. The ECI tracks employer labor costs for a defined employment sample; it is not a transaction-price index for nursing-home resident days, and it excludes important sources of price variation. The distinction is especially important when labor costs are one of several components of the provider's charge.

The BLS occupational outlook for home care aides (2026) projects substantial 2025–2035 employment growth in the U.S. occupation. A projection of worker demand is not a forecast of wage inflation: actual rates will depend on supply, immigration, training, reimbursement, technology, and regional labor conditions. It does, however, establish why the assumption that sufficient care hours can always be purchased at an indexed historical price deserves explicit stress testing.

The OECD's 2025 LTC workforce comparison reports an average of approximately five formal LTC workers per 100 people aged 65 and older in the 31-country comparable group for 2023, with wide national dispersion. This is a workforce density indicator, not a direct ratio of available caregiver hours to insured care needs. The OECD's working conditions investigation (2023) also identifies labor shortages, poor working conditions, and public financing constraints as determinants of care-sector capacity. These findings support scenarios involving higher wage costs, unmet demand, and substitution between providers rather than a mechanically fixed wage-to-price pass-through.

Price, utilization, access, and informal care

Care needs may be met through professional home care, family assistance, community services, and residential institutions. An increase in the opportunity cost of informal caregiving can raise paid service use at unchanged medical severity; a shortage of paid caregivers can push demand back toward families or leave needs unmet. Both mechanisms can cause a departure between measured insured claims and the welfare cost of dependency. The OECD analysis of care affordability explicitly identifies constrained family-care capacity and high out-of-pocket exposure.

An insurer may experience higher claims when beneficiaries substitute more expensive formal hours for family care. It may also experience temporarily lower cash utilization when formal care cannot be accessed, with eventual adverse outcomes from delays or higher acuity. Therefore lower claims during labor shortages should not automatically be interpreted as improved morbidity. The relevant evidence includes unmet-need surveys, hours billed, hours authorized, time until provider placement, and movement among care settings.

A provider price increase can be quality related. Regulation requiring greater staffing may increase cost while also improving resident safety. A fixed-service price index must identify whether the care package has changed. At the other extreme, providers may reduce service duration or quality to hold a quoted rate constant. A monetary trend cannot, by itself, reveal the welfare consequences of these adjustments. External consumer price measures and internal claim-level service utilization should be analyzed together.

Inflation protection and the erosion of nominal benefits

Contract terms determine how inflation passes to the insurer. Consider three stylized forms: reimbursement up to a daily cap, a fixed cash indemnity triggered by eligible dependency, and a reimbursement benefit with a cumulative lifetime pool. A claim dollar can increase with provider prices only while an applicable reimbursement ceiling remains unbound. Once the ceiling binds, the insurer's incremental payment may be zero despite a rising household expenditure. Fixed indemnity promises can instead raise insurer payments through the contractual benefit escalation rule, independently of the actual service bill.

For an illustrative current daily care bill of $250 growing at 5 percent annually for 20 years, the bill becomes approximately \$250 × 1.05^20 = \$663.32. If the insured daily maximum starts at $200 and increases by 3 percent annually, the maximum becomes approximately \$200 × 1.03^20 = \$361.22. Assuming eligible full-day use and no other restrictions, the household's daily funding gap then approaches $302.10. These numbers follow only from the assumed rates and cap; they are not survey observations or product quotations. A fixed maximum, simple escalation, compound escalation, attained-age limitations, and a shared benefit pool yield materially different outcomes.

The difference between the cost-growth factor and benefit-growth factor is [(1.05)/(1.03)]^20, approximately 1.47 in this illustration. That ratio expresses the widening relation between care price and benefit ceiling when both have an initial comparable unit; it is not a measured inflation shortfall for all long-term care policies. Insurer liabilities and policyholder adequacy can therefore diverge over time, making simultaneous measurement essential.

Premium and Reserve Stress

A transparent cash-flow identity

The expected present value of future insured benefits can be represented as an integral over active exposure and payable care states. Let π_s(u) denote the probability that an in-force insured person occupies payable state s at future duration u, let B_s(u) be the insurer's expected benefit-payment rate in that state after contractual limits and claim expenses, and let v(u) be an appropriate discount factor. An illustrative expected present value is EPV = ∫_0^T v(u) Σ_s π_s(u) B_s(u) du. A portfolio valuation aggregates the result across policies, adds expected expenses and other relevant cash flows, and applies the actual reporting and regulatory measurement requirements. This expression is a general actuarial identity, not a complete statutory reserve formula.

Underlying claim payments depend on incidence, claim continuance and transfer probabilities, service intensity, unit cost, and reimbursement rules. Under an uncapped simplified product, a useful approximate factorization of expected gross cost is Exposure × Incidence × Mean Duration × Mean Service Units per Time × Unit Price. Contractual liability requires a further benefit share or payment function. Since these factors vary by age and state and can be dependent, multiplying portfolio-wide averages is only a diagnostic. Exact projections should integrate over the joint state distribution and contract terms.

The materiality of dependencies can be expressed through elementary probability. For random claim quantity U and price P, E[UP] = E[U]E[P] + Cov(U,P). A model that substitutes the product of two independent forecasts silently sets the covariance to zero. During a workforce shortage, high-acuity episodes may be disproportionately concentrated in high-price facilities, creating a positive association. In other circumstances restricted access may reduce paid units as prices increase. The sign is empirical and should be tested or stressed rather than presumed.

Illustrative compound deterioration

Consider an entirely hypothetical block projected to generate a baseline undiscounted insured cost of $100 million under an unchanged uncapped payment design and fixed exposure. Suppose claim incidence is 10 percent greater than assumed, average payable duration is 15 percent greater, and comparable unit care prices are 20 percent greater, while intensity per claim period, benefit share, and discounting remain fixed. The multiplicative factor is 1.10 × 1.15 × 1.20 = 1.518. Expected gross claim cost becomes $151.8 million, an increase of 51.8 percent. The extra 0.8 percentage point beyond an incorrectly combined simple 51 percent reflects interaction among the three changes.

The $100 million baseline is an invented teaching input and the rates are stress assumptions. The example illustrates compounding, not a predicted industry loss. If reimbursement benefits are capped, the 20 percent provider-price change may have a smaller direct effect on insured payment, while households bear the residual. If deterioration extends claims into a more expensive facility, the original 'fixed intensity' assumption fails. If the shocks are correlated or mortality changes, an integrated stochastic model may produce further differences. The decomposition must be recomputed using the actual benefit function rather than applying 1.518 indiscriminately.

A separate hypothetical active-life illustration provides a check on units. Suppose 10,000 exposed policies each have a cumulative 20 percent probability of a qualifying episode over a defined horizon; each incurred episode produces three payable years at an annual covered service cost of $80,000, with an insurer-paid share of 65 percent. Ignoring discounting, mortality interactions, duration dispersion, and contract limits, the approximate expected payout is 10,000 × 0.20 × 3 × \$80,000 × 0.65 = \$312 million. This expression is useful only as a simplified dimensional check. It cannot replace a time-indexed expected present value or a model of claim paths and benefit exhaustion.

Premium sufficiency and legacy contracts

Premium adequacy depends on the expected lifetime relationship among premiums, claims, expenses, investments, lapses, and policy benefits. Historical fixed-premium or limited-repricing policies can accumulate mispricing that later experience studies reveal. The NAIC's overview of older LTCI blocks documents the interaction of unexpectedly low voluntary lapses, higher claim incidence, and longer claims in the U.S. experience. Low lapses increase survival of the insurance liability even when they may represent desirable consumer persistency. A premium stress should therefore test morbidity, cost trend, persistency, interest rates, and policyholder option behavior jointly.

The Government Accountability Office's rate-setting and claims oversight report (GAO 2008) documents historical differences among U.S. states in premium-increase decisions and consumer outcomes. The finding has a precise period and population: it does not describe each current state or rate filing. It establishes why projected indicated rate changes and premiums that can lawfully or operationally be collected are separate variables. Benefit-reduction elections, lapse responses to premium increases, and policyholder health selection can make a repricing response nonlinear.

The NAIC's multistate rate review framework (NAIC 2022, described in current regulator guidance) reflects attempts to coordinate actuarially appropriate premium requests while managing state-to-state disparities. A model should record assumptions about the timing and magnitude of achievable increases, administrative delay, product-specific repricing rights, and the distributional consequences for policyholders. An indicated premium increase is neither an already approved legal rate nor an immediate cash receipt.

Valuation under distinct reporting systems

Under IFRS 17 Insurance Contracts (IASB 2017, effective 2023), groups of contracts are measured using current estimates of fulfillment cash flows, including the timing of expected receipts and payments, a risk adjustment for nonfinancial risk, and where applicable a contractual service margin. Changes connected with future service can affect the contractual service margin in accordance with the standard, while losses from onerous groups have their own recognition treatment. A simple cash-flow stress is therefore informative but does not directly yield an IFRS 17 profit or liability movement without grouping, contract boundaries, risk adjustment, and accounting allocation.

The IFRS 17 key-terms explanation clarifies the distinction between the liability for remaining coverage and the liability for incurred claims. Long-term care claim continuance assumptions can affect both outstanding incurred-claim obligations and expectations for future covered episodes. Monetary cost shocks can occur after the original recognition date. The discount rates must be appropriate to liability characteristics; a forecast of asset returns is not freely interchangeable with a liability discount curve.

The U.S. Actuarial Standards Board's ASOP No. 18, Long-Term Care (ASB 2022) describes professional considerations applicable to actuarial services involving LTC programs and insurance. It is a professional standard within its defined applicability, rather than a global statute or a specific financial reporting regime. A practitioner must also consider the jurisdiction's adopted insurance valuation, rate regulation, actuarial opinion, and financial reporting requirements. This monograph treats the actuarial cash-flow model as an analytical base and deliberately avoids presenting it as identical under all jurisdictions.

Capital and enterprise stress

Long-tail liability shocks interact with asset duration, liquidity, credit risk, inflation sensitivity, and underwriting concentration. The International Association of Insurance Supervisors' Insurance Core Principles (IAIS 2024) set a supervisory framework including enterprise risk management and valuation. An insurer with large legacy LTC obligations needs integrated scenarios that recognize how higher costs, unexpected claim duration, adverse mortality interactions, and lower interest rates might coincide. Reserve adequacy and capital adequacy answer related but distinct questions: the first concerns the proper recognized and projected liability, while the second addresses resources available to withstand adverse outcomes under the applicable regime.

A credible stress program records at least the assumption shock, the horizon, the affected cohorts, dependence and behavioral reactions, and the actual valuation basis. Sensitivity results should show both dollar change and proportional change and identify the largest source of uncertainty. The model's precision must not exceed that of its incidence, termination, price, or contractual data. Governance should avoid interpreting a single deterministic severe scenario as a statistical confidence level.

Integrated Findings and Research Agenda

Interpretation of the joint risk

The evidence supports a disciplined distinction between five phenomena: aging of the insured exposure; change in age- and contract-specific incidence of eligible claims; change in claim-state duration and transitions; change in paid service mix and intensity; and change in the unit price of comparable care. An observed increase in aggregate insurer claims is an outcome of all five, combined with contractual payment limits, policyholder selection and financial discounting. Calling the entire increase 'medical inflation' or 'morbidity deterioration' discards information needed to value the promise.

The distinction has direct consequences for policyholder welfare. A dollar-denominated cap can insulate the insurer from some care-price changes while enlarging the customer's unfunded care requirement. A policy with automatic compound inflation protection can maintain a larger share of care purchasing power while increasing the insurer's long-tail exposure. Greater caregiver scarcity may simultaneously raise wages and reduce access; observed lower paid utilization in that setting can coexist with worse unmet need. Contract design and care-market capacity are therefore inseparable from interpreting the cost of insured protection.

The evidence also suggests why historical pricing problems should be understood jointly. The NAIC's LTCI historical account highlights actual experience that diverged from older assumptions for incidence, continuance, and lapse. Milliman's published projection methods separately parameterize morbidity, care setting, utilization and inflation. Combined, these sources show that the correct object of monitoring is the interaction among assumptions rather than a narrow calendar inflation factor. This is an analytical synthesis of existing actuarial concepts, not a claim to have discovered a new model.

Research propositions capable of empirical testing

Several implications can be formulated as empirical research questions without introducing new theoretical systems. Does care-cost growth predict higher insured dollars after controlling for benefit maximums and setting mix? Does the same provider-price change affect capped reimbursement and fixed-indemnity contracts differently? Do cohorts with greater access to informal care experience less paid formal service use conditional on functional dependency, and does the association change with caregiver labor supply? Does a calendar trend estimated from new claims persist when product generation, age, underwriting selection, and claim reporting delays are controlled? Are duration shocks mainly attributable to improved survival during dependency, slower recovery, different severity, or benefit-design differences? Does the insurer-paid share of eligible care expenditure decline over time in products whose benefit escalation lags local service prices?

Each question requires a particular unit of observation and counterfactual. The provider-price question needs transaction prices and service units, while the benefit-cap question also needs complete policy wording and remaining pool balances. The informal care question needs independent measurement of family assistance and functional severity. The claim-incidence question needs risk-set construction and reporting-development adjustment. The duration question requires cause-specific transitions with censoring. A cross-jurisdiction result requires comparable need measures and explicit adjustment for public entitlement design. The underlying limitations are productive: they specify what data could confirm or disconfirm a proposed relationship.

Editorial and actuarial governance implications

Internal actuarial review should require documentation of where source observations end and scenario assumptions begin. At each assumption review, the insurer should retain the data vintage, observation window, contract generation, definitions of incidence and duration, choice of care-price index, alternative scenarios, and the actual change to projected cash flows. Material changes must be traceable to recognized causes rather than unexplained balancing adjustments. When published survey medians or labor indexes are imported, the mapping to the portfolio's paid services requires a recorded justification.

The ASOP No. 18 professional standard offers a U.S. practice reference for this discipline; IFRS 17 and the IAIS supervisory principles supply distinct reporting and risk-governance contexts. They are not identical mandates, and a reporting-basis reconciliation is essential. National regulatory approval of LTC premium changes and contract modifications remains a separate legal inquiry from whether a model's indicated premium is economically sufficient.

For research institutions, useful next evidence would include linked functional-assessment and insurer-claim records with consent and legal protections, extended high-age exposure, claim-state transitions, policy benefit exhaustion, provider-level price and quality panels, and comparable household informal-care measures. Joint modeling of climate disruption, workforce shortages, public eligibility change, and regional care supply could extend the scenario set; these are research directions and established risk interactions rather than proposed proprietary doctrines. Their value lies in testing whether risk is properly transferred and funded for the actual care that people can obtain.

Conclusion

Morbidity trend and care cost inflation shape long-term care insurance through different observable processes whose effects are joined by insured eligibility and benefit design. Mortality and survival determine exposure to disability, functional-state transitions determine the timing and persistence of care, households and providers determine how much formal care is delivered, and service markets determine its price. Insurance contracts determine which part of that expenditure is payable by the insurer, subject to waiting periods, covered settings, daily or monthly caps, inflation protection, and remaining benefit pools. Financial valuation then converts those contingent payments into current obligations under the relevant accounting and regulatory system.

The review establishes three substantive conclusions. First, long-term claims development cannot be explained by a single unadjusted morbidity trend because aging, selection, claims definitions, occurrence, and continuance are different mechanisms. Second, care-price inflation must be observed alongside service units, setting mix, workforce capacity, and quality; headline survey medians, employer wages, and actual insurer reimbursement measure different quantities. Third, joint incidence, duration, and cost shocks can compound materially in projected obligations, but policy benefit limits may reroute the shock into household out-of-pocket expenditure. A reserve projection that is insensitive to provider prices may therefore coexist with deteriorating consumer protection rather than indicating a low social cost of care.

The resulting analytical standard is practical: define the insured state and exposure, preserve cause-specific transitions, measure comparable care units and their prices, apply the complete contractual payment function, test dependent multivariate scenarios, and record data and jurisdictional limitations. This synthesis clarifies the conditions under which morbidity trends and inflation are interpretable for pricing, reserving, solvency, and policyholder adequacy. It neither claims a universal numerical forecast nor introduces a new original theory. The research is complete as a documentary and analytic monograph subject to its stated evidence boundaries.

References